Naptumomab estafenatox

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Naptumomab estafenatox": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Naptumomab estafenatox

Articles

Most recent articles on Naptumomab estafenatox

Most cited articles on Naptumomab estafenatox

Review articles on Naptumomab estafenatox

Articles on Naptumomab estafenatox in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Naptumomab estafenatox

Images of Naptumomab estafenatox

Photos of Naptumomab estafenatox

Podcasts & MP3s on Naptumomab estafenatox

Videos on Naptumomab estafenatox

Evidence Based Medicine

Cochrane Collaboration on Naptumomab estafenatox

Bandolier on Naptumomab estafenatox

TRIP on Naptumomab estafenatox

Clinical Trials

Ongoing Trials on Naptumomab estafenatox at Clinical Trials.gov

Trial results on Naptumomab estafenatox

Clinical Trials on Naptumomab estafenatox at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Naptumomab estafenatox

NICE Guidance on Naptumomab estafenatox

NHS PRODIGY Guidance

FDA on Naptumomab estafenatox

CDC on Naptumomab estafenatox

Books

Books on Naptumomab estafenatox

News

Naptumomab estafenatox in the news

Be alerted to news on Naptumomab estafenatox

News trends on Naptumomab estafenatox

Commentary

Blogs on Naptumomab estafenatox

Definitions

Definitions of Naptumomab estafenatox

Patient Resources / Community

Patient resources on Naptumomab estafenatox

Discussion groups on Naptumomab estafenatox

Patient Handouts on Naptumomab estafenatox

Directions to Hospitals Treating Naptumomab estafenatox

Risk calculators and risk factors for Naptumomab estafenatox

Healthcare Provider Resources

Symptoms of Naptumomab estafenatox

Causes & Risk Factors for Naptumomab estafenatox

Diagnostic studies for Naptumomab estafenatox

Treatment of Naptumomab estafenatox

Continuing Medical Education (CME)

CME Programs on Naptumomab estafenatox

International

Naptumomab estafenatox en Espanol

Naptumomab estafenatox en Francais

Business

Naptumomab estafenatox in the Marketplace

Patents on Naptumomab estafenatox

Experimental / Informatics

List of terms related to Naptumomab estafenatox

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Naptumomab estafenatox is a monoclonal antibody and which it is used to treat cancers. It has a chelator, estafenatox. It binds to 5T4 Fab.

Template:SIB Template:WH Template:WikiDoc Sources